Clinical Trial Update: The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Goserelin plus Fulvestrant with Goserelin plus Anastrozole in advanced/metastatic breast cancer; the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)
• Goserelin (Goserelin)

Snippet

Sponsor: Hospital Affiliated to Military Medical Science, Beijing | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN